Skip to Main Content

Author Details

Diane Palmieri
Center for Cancer Research
1987
55
42
PMIDPaper TitleJournal TitlePublished Year
27245829Alterations in Pericyte Subpopulations Are Associated with Elevated Blood-Tumor Barrier Permeability in Experimental Brain Metastasis of Breast Cancer.Clin Cancer Res2016
27245829Alterations in Pericyte Subpopulations Are Associated with Elevated Blood-Tumor Barrier Permeability in Experimental Brain Metastasis of Breast Cancer.Clin Cancer Res2016
25591736LAMC2 enhances the metastatic potential of lung adenocarcinoma.Cell Death Differ2015
25591736LAMC2 enhances the metastatic potential of lung adenocarcinoma.Cell Death Differ2015
26319493Analysis of radiation therapy in a model of triple-negative breast cancer brain metastasis.Clin Exp Metastasis2015
26479035Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth.Nature2015
26479035Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth.Nature2015
26319493Analysis of radiation therapy in a model of triple-negative breast cancer brain metastasis.Clin Exp Metastasis2015
24634373Profound prevention of experimental brain metastases of breast cancer by temozolomide in an MGMT-dependent manner.Clin Cancer Res2014
24634373Profound prevention of experimental brain metastases of breast cancer by temozolomide in an MGMT-dependent manner.Clin Cancer Res2014
24948741DNA double-strand break repair genes and oxidative damage in brain metastasis of breast cancer.J Natl Cancer Inst2014
24948741DNA double-strand break repair genes and oxidative damage in brain metastasis of breast cancer.J Natl Cancer Inst2014
23583652Pazopanib inhibits the activation of PDGFRβ-expressing astrocytes in the brain metastatic microenvironment of breast cancer cells.Am J Pathol2013
24002934Paclitaxel-hyaluronic nanoconjugates prolong overall survival in a preclinical brain metastases of breast cancer model.Mol Cancer Ther2013
24298071CNS metastases in breast cancer: old challenge, new frontiers.Clin Cancer Res2013
23583652Pazopanib inhibits the activation of PDGFRβ-expressing astrocytes in the brain metastatic microenvironment of breast cancer cells.Am J Pathol2013
24298071CNS metastases in breast cancer: old challenge, new frontiers.Clin Cancer Res2013
24002934Paclitaxel-hyaluronic nanoconjugates prolong overall survival in a preclinical brain metastases of breast cancer model.Mol Cancer Ther2013
22011930Lapatinib distribution in HER2 overexpressing experimental brain metastases of breast cancer.Pharm Res2012
22741041In Vivo Magnetic Resonance Imaging for Investigating the Development and Distribution of Experimental Brain Metastases due to Breast Cancer.Transl Oncol2012
22622283TPI-287, a new taxane family member, reduces the brain metastatic colonization of breast cancer cells.Mol Cancer Ther2012
22911670Effect of inhibition of the lysophosphatidic acid receptor 1 on metastasis and metastatic dormancy in breast cancer.J Natl Cancer Inst2012
23217186The role of MMP-1 in breast cancer growth and metastasis to the brain in a xenograft model.BMC Cancer2012
22011930Lapatinib distribution in HER2 overexpressing experimental brain metastases of breast cancer.Pharm Res2012
22215693Opposing effects of pigment epithelium-derived factor on breast cancer cell versus neuronal survival: implication for brain metastasis and metastasis-induced brain damage.Cancer Res2012
23217186The role of MMP-1 in breast cancer growth and metastasis to the brain in a xenograft model.BMC Cancer2012
22741041In Vivo Magnetic Resonance Imaging for Investigating the Development and Distribution of Experimental Brain Metastases due to Breast Cancer.Transl Oncol2012
22911670Effect of inhibition of the lysophosphatidic acid receptor 1 on metastasis and metastatic dormancy in breast cancer.J Natl Cancer Inst2012
22622283TPI-287, a new taxane family member, reduces the brain metastatic colonization of breast cancer cells.Mol Cancer Ther2012
22215693Opposing effects of pigment epithelium-derived factor on breast cancer cell versus neuronal survival: implication for brain metastasis and metastasis-induced brain damage.Cancer Res2012
21081656Pazopanib reveals a role for tumor cell B-Raf in the prevention of HER2+ breast cancer brain metastasis.Clin Cancer Res2011
21081656Pazopanib reveals a role for tumor cell B-Raf in the prevention of HER2+ breast cancer brain metastasis.Clin Cancer Res2011
21998674The B-Raf status of tumor cells may be a significant determinant of both antitumor and anti-angiogenic effects of pazopanib in xenograft tumor models.PLoS One2011
21665937Notch1 inhibition alters the CD44hi/CD24lo population and reduces the formation of brain metastases from breast cancer.Mol Cancer Res2011
21953073Inhibition of Polo-like kinase 1 prevents the growth of metastatic breast cancer cells in the brain.Clin Exp Metastasis2011
21998674The B-Raf status of tumor cells may be a significant determinant of both antitumor and anti-angiogenic effects of pazopanib in xenograft tumor models.PLoS One2011
21953073Inhibition of Polo-like kinase 1 prevents the growth of metastatic breast cancer cells in the brain.Clin Exp Metastasis2011
21665937Notch1 inhibition alters the CD44hi/CD24lo population and reduces the formation of brain metastases from breast cancer.Mol Cancer Res2011
20303257Translational research in brain metastasis is identifying molecular pathways that may lead to the development of new therapeutic strategies.Eur J Cancer2010
20829328Heterogeneous blood-tumor barrier permeability determines drug efficacy in experimental brain metastases of breast cancer.Clin Cancer Res2010
20303257Translational research in brain metastasis is identifying molecular pathways that may lead to the development of new therapeutic strategies.Eur J Cancer2010
20829328Heterogeneous blood-tumor barrier permeability determines drug efficacy in experimental brain metastases of breast cancer.Clin Cancer Res2010
19509253Vorinostat enhances the radiosensitivity of a breast cancer brain metastatic cell line grown in vitro and as intracranial xenografts.Mol Cancer Ther2009
19723875Analyses of resected human brain metastases of breast cancer reveal the association between up-regulation of hexokinase 2 and poor prognosis.Mol Cancer Res2009
19509253Vorinostat enhances the radiosensitivity of a breast cancer brain metastatic cell line grown in vitro and as intracranial xenografts.Mol Cancer Ther2009
19789319Vorinostat inhibits brain metastatic colonization in a model of triple-negative breast cancer and induces DNA double-strand breaks.Clin Cancer Res2009
19774344Uptake of ANG1005, a novel paclitaxel derivative, through the blood-brain barrier into brain and experimental brain metastases of breast cancer.Pharm Res2009
19840404Rat model of metastatic breast cancer monitored by MRI at 3 tesla and bioluminescence imaging with histological correlation.J Transl Med2009
19840404Rat model of metastatic breast cancer monitored by MRI at 3 tesla and bioluminescence imaging with histological correlation.J Transl Med2009
19789319Vorinostat inhibits brain metastatic colonization in a model of triple-negative breast cancer and induces DNA double-strand breaks.Clin Cancer Res2009
  • 1 - 50 of 110

Recommended Authors

Jalna Meens
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2004
Number of shared co-authors 0
Arnulfo Mendoza
National Cancer Institute, National Institutes of Health
Career Start Year 2004
Number of shared co-authors 9
Joshua Chuck Harrell
Virginia Commonwealth University
Career Start Year 2002
Number of shared co-authors 0
Anupama E Gururaj
National Institute of Allergy and Infectious Disease, National Institutes of Health
Career Start Year 2002
Number of shared co-authors 2
Alana L Welm
Huntsman Cancer Institute, University of Utah
Career Start Year 1999
Number of shared co-authors 1
Annette T Byrne
Royal College of Surgeons in Ireland (RCSI)
Career Start Year 1999
Number of shared co-authors 0
Krishna P Bhat
Department of Neurosurgery at the University of Texas MD Anderson Cancer Center
Career Start Year 1998
Number of shared co-authors 2
Theresa M LaVallee
Parker Institute for Cancer Immunotherapy
Career Start Year 1996
Number of shared co-authors 0
Shi-Yuan Cheng
Northwestern University Feinberg School of Medicine
Career Start Year 1996
Number of shared co-authors 0
William M Gallagher
All-Island Cancer Research Institute, UCD Conway Institute, University College Dublin
Career Start Year 1996
Number of shared co-authors 1
Kan V Lu
Clinical Medical Research Center of Hepatic Surgery at Hubei Province
Career Start Year 1995
Number of shared co-authors 0
Zhaomei Mu
Thomas Jefferson University Hospital
Career Start Year 1994
Number of shared co-authors 0
Paul N Span
Radboud University Medical Center
Career Start Year 1993
Number of shared co-authors 1
Ernst Lengyel
University of Chicago
Career Start Year 1993
Number of shared co-authors 0
Rozita Bagheri-Yarmand
The University of Texas MD Anderson Cancer Center
Career Start Year 1992
Number of shared co-authors 0
Barry R Davies
Oncology R&D
Career Start Year 1992
Number of shared co-authors 0
Mai Nguyen
University of California Riverside
Career Start Year 1992
Number of shared co-authors 0
Liana Adam
The University of Texas MD Anderson Cancer Center
Career Start Year 1992
Number of shared co-authors 1
Ramona F Swaby
Merck & Co., Inc.
Career Start Year 1991
Number of shared co-authors 1
Ben Ho Park
Vanderbilt University Medical Center
Career Start Year 1990
Number of shared co-authors 3
Emile E Voest
The Netherlands Cancer Institute
Career Start Year 1989
Number of shared co-authors 1
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 2
Luc Dirix
GZA Ziekenhuizen Campus Sint-Augustinus, University of Antwerp
Career Start Year 1988
Number of shared co-authors 1
Rakesh Kumar
Rutgers New Jersey Medical School
Career Start Year 1987
Number of shared co-authors 1
Kenneth R Hess
The University of Texas MD Anderson Cancer Center
Career Start Year 1986
Number of shared co-authors 2
Erwin G Van Meir
Heersink School of Medicine, University of Alabama at Birmingham
Career Start Year 1984
Number of shared co-authors 1
Adrian L Harris
University of Oxford
Career Start Year 1981
Number of shared co-authors 1
Christopher C Benz
Buck Institute for Research on Aging
Career Start Year 1977
Number of shared co-authors 5
Menashe Bar-Eli
The University of Texas MD Anderson Cancer Center
Career Start Year 1975
Number of shared co-authors 4
Dennis J Slamon
David Geffen School of Medicine at university of california los angeles
Career Start Year 1973
Number of shared co-authors 1

Collaborators

Patricia S Steeg
Center for Cancer Research, National Cancer Institute
Co-authored papers 42
Seth M Steinberg
Center for Cancer Research, National Cancer Institute
Co-authored papers 14
David J Liewehr
Center for Cancer Research
Co-authored papers 12
Yongzhen Qian
Co-authored papers 11
Emily Hua
Center for Cancer Research
Co-authored papers 8
Julie L Bronder
Center for Cancer Training, National Cancer Institute, National Institutes of Health
Co-authored papers 7
Quentin R Smith
School of Pharmacy, Texas Tech University Health Sciences Center
Co-authored papers 7
Paul R Lockman
Department of Pharmaceutical Sciences, School of Pharmacy, West Virginia University
Co-authored papers 7
Kevin Camphausen
National Cancer Institute
Co-authored papers 5
Rajendar K Mittapalli
Pfizer Inc.
Co-authored papers 5
Andreas M Stark
Schleswig-Holstein University Medical Center
Co-authored papers 5
Robert J Weil
Rhode Island Hospital
Co-authored papers 5
Kunal S Taskar
Drug Metabolism and Pharmacokinetics
Co-authored papers 4
Paul S Meltzer
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 4
Maria J Merino
National Cancer Institute, National Institutes of Health
Co-authored papers 4
Eleazar Vega-Valle
Co-authored papers 4
Vinay Rudraraju
Co-authored papers 4
Daniel P Fitzgerald
National Cancer Institute
Co-authored papers 4
Helen R Thorsheim
School of Pharmacy, Texas Tech University Health Sciences Center
Co-authored papers 4
Jeanne M Herring
Program Resources Inc. NCI-FCDRC
Co-authored papers 4
Kaci A Bohn
Department of Pharmaceutical Sciences, Harding University
Co-authored papers 3
Suyun Huang
Virginia Commonwealth University
Co-authored papers 3
Lionel Feigenbaum
Science Applications International Corporation/Frederick
Co-authored papers 3
Julie A Gaasch
Co-authored papers 3
Kenneth Aldape
National Cancer Institute
Co-authored papers 3
Elizabeth Hargrave
Co-authored papers 2
Susan R Davis
Co-authored papers 2
Toshiyuki Yoneda
Co-authored papers 2
Raffael Kurek
Oncology Clinical Development
Co-authored papers 2
Abdel G Elkahloun
National Human Genome Research Institute
Co-authored papers 2
Release 1.2